Tranexamic acid (trans-4-aminomethylcyclohexane-l-carboxylic acid, Transamin), an antifibrino lytic agent potentiated the venoconstriction induced by bradykinin in the perfused saphenous vein in rabbits.
A rabbit was anesthetized with pentobarbital sodium, 30 mg/kg, intravenously, and fixed on its back. The saphenous vein was exposed at the distal and proximal portions about 5 cm apart.
A polyethylene tube (PE 60) connected to the perfusion apparatus was inserted into the distal The simultaneous injection of tranexamic acid, 250 to 500 pg, definitely enhanced the venocon stricting action of bradykinin as shown in Fig. 1 , the outflow being reduced by about 70% or more.
A similar potentiation was observed when the perfusate had been changed to that containing tranexamic acid, 100 to 200 pg/m1, 5 minutes before the injection of bradykinin.
Tranexamic acid per se caused no significant changes in the outflow. It lacked obvious effects on the venoconstriction produced by histamine, 0.2 to 2,"g. A mixed preparation containing tranexamic acid and its cis-isomer in I : 3 also exhibited a similar potency in enhancing bradykinin effect. This finding is not consistent with an explanation that the potentiation is directly connected with the antifibrinolytic activity, since the cis-isomer had been reported to be a very weak antifibrinolytic agent (1). Detailed analyses are under way in order to specify the action of tranexamic acid. 
